StockData
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

CapsoVision, Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$6.67+0.14 (+2.14%)

Close on Oct 19, 2026

Market cap
$333.08M
P/E (TTM)
–
Dividend yield
–

Margins

Share of revenue, fiscal years 2023 to 2025

Gross margin

52.9%

Operating margin

-188.3%

Net margin

-186.8%